Another one walks out of the hospital. Wonder what
Post# of 148281
Someone posted that "common sense" suggests that EUA would make enrolling patients in CD16 & CD17 impossible. Who would risk getting placebo.
If EUA were granted for 14 day results & 2 doses, it just seems that the "common sense" approach would be that all patients would receive either 2 or 4 doses of LL.
This should be especially true when PE is decreased hospital stay, as this should be well established where placebo is concerned.